HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.

Abstract
Diallyl disulfide (DADS) is an oil-soluble organosulfur compound found in garlic. The effect of synthetic DADS on the growth of estrogen receptor (ER)-positive (KPL-1 and MCF-7) and -negative (MDA-MB-231 and MKL-F) human breast cancer cell lines was examined. In an in vitro MTT assay, regardless of ER status, DADS at an IC(50) of 1.8-18.1 microM after 72 h incubation caused inhibition of growth in all four cell lines examined. Growth inhibition was due to apoptosis as seen by the appearance of a sub G1 fraction. In MDA-MB-231 cells, the apoptosis cascade comprised up-regulation of Bax protein (142%), down-regulation of Bcl-X(L) protein (38%) and activation of caspase-3 (438%) compared with controls. In an in vivo assay by orthotopic (right thoracic mammary fat pad) transplantation of KPL-1 cells in female nude mice, intraperitoneal injection of 1 or 2 mg DADS three times a week from the day of tumor cell inoculation until the end of the experiment (after 35 days) caused growth retardation and 43% reductions in primary tumor weight, respectively, compared with DADS-untreated mice without apparent side effects. Cell proliferation as evaluated by proliferating cell nuclear antigen (PCNA)-labeling in transplanted tumor of DADS-untreated mice was 59.6%, and 1 and 2 mg DADS-treated mice was 44.6 and 44.5%, respectively. In MDA-MB-231 cells, DADS antagonized the effect of linoleic acid (LA), a potent breast cancer cell stimulator (at DADS = 1.8 microM and LA > or = 6.5x10(2) microM concentration), and synergized the effect of eicosapentaenoic acid (EPA), a potent breast cancer cell suppressor (at DADS >3 x 10(-3) microM and EPA > 6.3 x 10(-1) microM concentration). Thus, DADS could be a promising anticancer agent for both hormone-dependent and -independent breast cancers, and may harmonize with polyunsaturated fatty acids known as modulators of breast cancer cell growth.
AuthorsH Nakagawa, K Tsuta, K Kiuchi, H Senzaki, K Tanaka, K Hioki, A Tsubura
JournalCarcinogenesis (Carcinogenesis) Vol. 22 Issue 6 Pg. 891-7 (Jun 2001) ISSN: 0143-3334 [Print] England
PMID11375895 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allyl Compounds
  • Antineoplastic Agents
  • Arachidonic Acids
  • Disulfides
  • Growth Inhibitors
  • Receptors, Estrogen
  • diallyl disulfide
  • Linoleic Acid
Topics
  • Allyl Compounds (pharmacology)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects, physiology)
  • Arachidonic Acids (pharmacology)
  • Breast Neoplasms (drug therapy, pathology)
  • Cell Division (drug effects)
  • Diet
  • Disulfides (pharmacology)
  • Drug Synergism
  • Female
  • Flow Cytometry
  • Growth Inhibitors (pharmacology)
  • Humans
  • Inhibitory Concentration 50
  • Linoleic Acid (antagonists & inhibitors, pharmacology)
  • Lymphatic Metastasis
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Receptors, Estrogen (physiology)
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: